Match tier Listed
Presence Formerly Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-04

Navya Nalajala

Role not yet determined Is this you? Add your title

Formerly Arkansas Affiliated with UAMS through 2023; recent publications list University of Mississippi.

2 h-index 3 pubs 19 cited

  • Atorvastatin
  • Tablets
  • Bulk Drugs
  • Chemistry, Pharmaceutical
  • Drug Compounding
  • Excipients
  • Polyethylene Glycols
  • Polymers
  • Powders
  • Solubility
  • Technology, Pharmaceutical
  • Poloxamer
  • Drug Liberation
  • Printing, Three-Dimensional

Biography and Research Information

OverviewAI-generated summary

Navya Nalajala's research focuses on pharmaceutical formulation and drug delivery, particularly investigating novel methods for creating solid dosage forms. Recent work includes studies on the direct powder extrusion of atorvastatin for immediate-release 3D-printed tablets, examining their solid-state characteristics and dissolution performance. Nalajala also explored the use of starch 1500® as a standalone green excipient for eco-friendly selective laser sintered 3D-printed tablets. This work contributes to the development of advanced pharmaceutical manufacturing techniques and the utilization of sustainable materials in drug formulation. Nalajala has published three papers, with a total of 19 citations and an h-index of 2.

Metrics

  • h-index: 2
  • Publications: 3
  • Citations: 19

Selected Publications

  • Immunizing hearts: exploring the vaccination frontier in heart failure management (2023)
    Annals of Medicine and Surgery 4 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

12 Collaborators 11 Institutions 8 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics